Monday - February 9, 2026
Semaglutide Improves Cardiovascular Health But Price Reductions Are Needed To Make It Cost-Effective, Study Finds
February 05, 2026
BOSTON, Massachusetts, Feb. 5 (TNSjou) -- Beth Israel Deaconess Medical Center issued the following news:

* * *

Semaglutide Improves Cardiovascular Health but Price Reductions Are Needed To Make It Cost-Effective, Study Finds

Study Coincides With Ongoing Negotiations To Bring Down Semaglutide Prices

*

Semaglutide, the active ingredient in the weight-loss medications Ozempic and Wegovy, offers substantial cardiovascular benefits for . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products